[fcb5af]: / literature / by_gene / CCL4.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 29467841 10.3892/etm.2017.5678 2022 Hepatoprotective effect of methyl ferulic acid against carbon tetrachloride-induced acute liver injury in rats. CCL4
2 33024918 10.1002/hep4.1540 2022 Deficiency of miR-208a Exacerbates CCl<sub>4</sub>-Induced Acute Liver Injury in Mice by Activating Cell Death Pathways. CCL4
3 33605486 10.1113/EP089328 2022 Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways. CCL4
4 34466471 10.31661/gmj.v8i0.1204 2022 Effects of Olive Leaf Extract on Prevention of Molecular, Histopathological, and Enzymatic Changes in Chicken Carbon Tetrachloride-Induced Liver Damage. CCL4
5 34727170 10.1182/bloodadvances.2021005522 2022 Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. CCL4
6 34872475 10.2174/1566524021666211206094046 2022 PAX5 Haploinsufficiency Induces Low T Cell Infiltration in the Cancer Microenvironment via Reduced Chemokines. CCL4
7 34915482 10.1159/000521445 2022 STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma. CCL4
8 34923584 10.1093/jpp/rgab164 2022 Specnuezhenide reduces carbon tetrachloride-induced liver injury in mice through inhibition of oxidative stress and hepatocyte apoptosis. CCL4
9 35008176 10.3390/cancers14010009 2022 Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue. CCL4
10 35236242 10.1080/15376516.2022.2046668 2022 Ellagic acid inhibits proinflammatory intermediary manufacture by suppressing NF-κB/Akt, VEGF and activating Nrf-2/Caspase-3 signaling pathways in rat testicular damage: a new way for testicular damage cure and <i>in silico</i> approach. CCL4
11 35356144 10.12965/jer.2244002.001 2022 Treadmill exercise ameliorates ethanol with lipopolysaccharide and carbon tetrachloride-mediated liver injury in mice. CCL4
12 35571331 10.1016/j.fochx.2022.100322 2022 Recent developments in <i>Moringa oleifera</i> Lam. polysaccharides: A review of the relationship between extraction methods, structural characteristics and functional activities. CCL4
13 35893891 10.3390/nu14153037 2022 Shibi Tea (<i>Adinandra nitida</i>) and Camellianin A Alleviate CCl<sub>4</sub>-Induced Liver Injury in C57BL-6J Mice by Attenuation of Oxidative Stress, Inflammation, and Apoptosis. CCL4
14 31768871 10.1007/s11655-019-3043-5 2021 Antioxidant and Antiapoptotic Polyphenols from Green Tea Extract Ameliorate CCl<sub>4</sub>-Induced Acute Liver Injury in Mice. CCL4
15 32250487 10.1111/jfbc.13217 2021 The preventive effect of ellagic acid on brain damage in rats via regulating of Nrf-2, NF-kB and apoptotic pathway. CCL4
16 32378684 10.1039/d0fo00575d 2021 Polysaccharides from Enteromorpha prolifera protect against carbon tetrachloride-induced acute liver injury in mice via activation of Nrf2/HO-1 signaling, and suppression of oxidative stress, inflammation and apoptosis. CCL4
17 32866262 10.1093/femspd/ftaa049 2021 Dissecting the Helicobacter pylori-regulated transcriptome of B cells. CCL4
18 33091494 10.1016/j.jep.2020.113496 2021 Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis. CCL4
19 33142237 10.1016/j.neo.2020.10.004 2021 SHC014748M, a novel selective inhi-bitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B cell lymphomas and chronic lymphocytic leukemia. CCL4
20 33455449 10.1080/08923973.2020.1869255 2021 The impact of ellagic acid on some apoptotic gene expressions: a new perspective for the regulation of pancreatic Nrf-2/NF-κB and Akt/VEGF signaling in CCl<sub>4</sub>-induced pancreas damage in rats. CCL4
21 33477957 10.3390/cancers13020354 2021 Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib in CLL Cells. CCL4
22 33666760 10.1007/s00262-021-02895-7 2021 Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy. CCL4
23 34174847 10.1186/s12885-021-08475-3 2021 Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma. CCL4
24 34764756 10.1016/j.sjbs.2021.07.014 2021 New phthalimide analog ameliorates CCl<sub>4</sub> induced hepatic injury in mice via reducing ROS formation, inflammation, and apoptosis. CCL4
25 34899328 10.3389/fphar.2021.772635 2021 Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism. CCL4
26 30550941 10.1016/j.jconrel.2018.12.010 2020 Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release. CCL4
27 30917711 10.1080/08820139.2019.1588291 2020 The Immuno-Enhancement Effects of Tubiechong <i>(Eupolyphaga sinensis)</i> Lyophilized Powder in Cyclophosphamide-Induced Immunosuppressed Mice. CCL4
28 30940905 10.1038/s41375-019-0458-0 2020 Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia. CCL4
29 31640181 10.3390/ijms20205215 2020 Protective Effects of Flavone from <i>Tamarix aphylla</i> against CCl<sub>4</sub>-Induced Liver Injury in Mice Mediated by Suppression of Oxidative Stress, Apoptosis and Angiogenesis. CCL4
30 31885062 10.1007/s11356-019-07352-8 2020 Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities. CCL4
31 32168755 10.3390/cancers12030650 2020 Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment. CCL4
32 33271005 10.5213/inj.2040430.215 2020 Protective Effect of Polydeoxyribonucleotide Against CCl4-Induced Acute Liver Injury in Mice. CCL4
33 29340070 10.18632/oncotarget.22847 2019 A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models. CCL4
34 29449436 10.3324/haematol.2017.182048 2019 Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients. CCL4
35 28036258 10.18632/oncotarget.14243 2018 Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk. CCL4
36 28103144 10.1080/10495398.2016.1268621 2018 Role of Different Natural Antioxidants in the Modulation of mRNA-expression of Apoptotic Molecules in the Livers of Carbon Tetrachloride-Intoxicated Rats. CCL4
37 28627620 10.3892/ijmm.2017.3028 2018 Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice. CCL4
38 28713991 10.3892/mmr.2017.6936 2018 Pien Tze Huang Gan Bao attenuates carbon tetrachloride‑induced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress. CCL4
39 29293620 10.1371/journal.pone.0190468 2018 Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma. CCL4
40 29717768 10.3892/ijmm.2018.3651 2018 Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation. CCL4
41 28389593 10.4049/jimmunol.1601607 2017 CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells. CCL4
42 29127109 10.1124/jpet.117.244947 2017 INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid Malignancies. CCL4
43 24862743 10.1111/exd.12455 2016 Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma. CCL4
44 25586606 10.3109/10428194.2014.991731 2016 Nurse like cells: chronic lymphocytic leukemia associated macrophages. CCL4
45 25589626 10.1158/1078-0432.CCR-14-2355 2016 Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. CCL4
46 26115646 10.1016/j.prostaglandins.2015.06.004 2016 Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells. CCL4
47 26358140 10.1111/bjh.13659 2016 CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. CCL4
48 26441060 10.1007/s11010-015-2572-2 2016 Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury. CCL4
49 25131731 10.1016/j.vaccine.2014.07.103 2015 Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant. CCL4
50 25164110 10.1002/ajh.23838 2015 Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma. CCL4
51 26062544 10.1186/s40659-015-0022-y 2015 Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl4-induced hepatotoxicity in rats. CCL4
52 24693884 10.1186/1475-2867-14-32 2014 Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment. CCL4
53 25008236 10.1186/1479-5876-12-191 2014 Ipilimumab augments antitumor activity of bispecific antibody-armed T cells. CCL4
54 22356114 10.3109/10428194.2012.668287 2013 Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation. CCL4
55 22980495 10.1179/1607845412Y.0000000028 2013 Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity. CCL4
56 23089690 10.1016/j.jfma.2011.06.026 2013 Green tea extract supplementation ameliorates CCl4-induced hepatic oxidative stress, fibrosis, and acute-phase protein expression in rat. CCL4
57 23152559 10.4049/jimmunol.1201018 2013 Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. CCL4
58 23940282 10.1182/blood-2013-02-482125 2013 Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients. CCL4
59 21364752 10.1371/journal.pone.0016596 2011 Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines. CCL4
60 21392167 10.1111/j.1349-7006.2011.01924.x 2011 Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma. CCL4
61 21744323 10.5603/fhc.2011.0033 2011 Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma. CCL4
62 18177436 10.1111/j.1751-553X.2007.01014.x 2009 Multiple osteolytic bone lesions with high serum levels of interleukin-6 and CCL chemokines in a patient with adult T cell leukemia. CCL4
63 17935139 10.1002/ijc.23119 2008 Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. CCL4
64 17938867 10.1007/s11010-007-9617-0 2008 Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats. CCL4
65 16964309 10.1172/JCI24274 2007 Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. CCL4
66 17475893 10.4049/jimmunol.178.10.6616 2007 The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximab. CCL4
67 17540847 10.1182/blood-2006-06-032938 2007 Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. CCL4
68 16263571 10.1080/10428190500175049 2006 Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. CCL4
69 16287062 10.1002/ijc.21579 2006 Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival. CCL4
70 16019547 10.1080/10428190500066636 2005 Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1a) in human multiple myeloma. CCL4
71 14561785 10.1203/01.PDR.0000099773.71438.91 2004 Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. CCL4
72 14565645 10.3109/10428190309178765 2004 New insights in myeloma-induced osteolysis. CCL4
73 14965375 10.1089/10430340460732436 2004 CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine. CCL4
74 15005344 10.1532/ijh97.03006 2004 Primary adult T-cell leukemia/lymphoma of bone. CCL4
75 15101731 10.1080/10428190310001593139 2004 Diffuse large B-cell lymphoma presenting with hypercalcemia and multiple osteolysis. CCL4
76 15176993 10.1359/JBMR.040314 2004 Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia. CCL4
77 15350537 10.1016/j.yexcr.2004.06.018 2004 Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells. CCL4
78 12527943 10.3892/ijo.22.2.421 2003 A phase II protection study of BB-10010 in patients with high grade non-Hodgkin's lymphoma undergoing intensive chemotherapy. CCL4
79 12721796 10.1007/s00705-002-0971-7 2003 Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. CCL4
80 12769791 10.2174/1568005033481178 2003 Current perspectives on cytokines for anti-retroviral therapy in AIDS related B-cell lymphomas. CCL4
81 11756152 10.1182/blood.v99.1.52 2002 CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. CCL4
82 12377948 2002 Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. CCL4
83 11064099 10.1016/s0165-2478(00)00258-3 2001 CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator. CCL4
84 11602733 10.1128/JVI.75.22.10933-10940.2001 2001 Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. CCL4
85 10616208 2000 MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. CCL4
86 10747947 10.1074/jbc.M000689200 2000 Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. CCL4
87 10779418 2000 HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. CCL4
88 10830743 10.3109/10428190009087027 2000 The role of chemokines in Hodgkin's disease. CCL4
89 10419655 10.1006/cyto.1998.0439 1999 Abundant expression of chemokines in malignant and infective human lymphadenopathies. CCL4
90 10467937 10.1046/j.0909-8836.1999.eos107401.x 1999 Chemokine gene expression in human oral mucosa. CCL4
91 9414293 1998 Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. CCL4
92 9432038 10.1046/j.1365-2141.1997.4913294.x 1998 A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer. CCL4
93 9446638 1998 Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. CCL4
94 9477130 10.3109/10428199709058315 1998 Comparison of the effects of AcSDKP, thymosin beta4, macrophage inflammatory protein 1alpha and transforming growth factor beta on human leukemic cells. CCL4
95 9573029 1998 Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. CCL4
96 9669675 10.3109/10428199809050928 1998 The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemias. CCL4
97 9714521 10.1111/j.1600-0609.1998.tb01068.x 1998 Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy. CCL4
98 8939871 10.1126/science.274.5293.1739 1997 Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. CCL4
99 8996247 10.1084/jem.185.1.111 1997 The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. CCL4
100 9062350 10.1172/JCI119257 1997 Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. CCL4